Indian firms may garner up to 50% of USFDA nod share in 2023
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
- Latest
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
© 2023 Blitz India Media -BlitzIndia Building A New Nation